|
|
 |
CDC: COVID-19 vaccines recommended for young children - 2022/06/27 - |
|
FDA Approves Risankizumab-rzaa for Moderately to Severely Active Crohn Disease - 2022/06/21 - |
|
FDA Withdraws Umbralisib Due to Elevated Mortality Risk - 2022/06/6 - |
|
Could some arthritis drugs reduce Alzheimer and related dementias risk in those with heart disease? - 2022/05/16 - |
|
Cardiac Issues After COVID Infection and Vaccination: New Data - 2022/04/24 - |
|
FDA Panel: Concerns Over PI3K Inhibitors in Blood Cancers - 2022/04/24 - |
|
Pembrolizumab vs. placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma - 2022/04/5 - |
|
Audio Interview: Effectiveness of Covid-19 Vaccination in Children - 2022/04/5 - |
|
Compatibility of Commonly Used IV Drugs - 2022/02/20 - |
|
FDA Delays Advisory Meeting for COVID-19 Vaccine for Very Young Kids - 2022/02/13 - |
|
Omicron’s Differences, Sense of Smell, Effects on the Brain and Other News - 2022/02/13 - |
|
FDA Limits Use of Monoclonal Antibodies to Treat COVID-19 - 2022/01/26 - |
|
EHR Tool Flags Iron Deficiency In Heart Failure - 2022/01/16 - |
|
Omicron wave: 9 in 10 pharmacies struggling with staff absences - 2022/01/16 - |
|
No more annual flu shot? New target for universal influenza vaccine - 2022/01/8 - |
|
Could vitamin D deficiency increase the risk of heart disease? - 2022/01/8 - |
|
Immune Cell Population Potentially Responsible for Inflammation in Multiple Sclerosis - 2022/01/1 - |
|
Coronavirus Can Spread to Heart, Brain Days After Infection - 2021/12/29 - |
|
FDA Gives Nod to Tralokinumab for Adults With Moderate to Severe AD - 2021/12/29 - |
|
Japan Health Panel Approves Merck's Oral COVID-19 Treatment - 2021/12/28 - |
|
Positive Phase 3 Topline Results for Early Parkinson's Drug - 2021/12/28 - |
|
Abrocitinib Approved for Atopic Dermatitis in Europe - 2021/12/14 - |
|
Major COVID-19 Case Growth Expected in Coming Weeks - 2021/12/14 - |
|
Feds Go on Offense Ahead of Potential Omicron Spread in US - 2021/12/5 - |
|
New COVID Variant of Concern Drives US Travel Bans - 2021/11/27 - |
|
Anticoagulants Can Ease Cognitive Decline in AF Patients - 2021/11/27 - |
|
Pfizer Announces Agreement with US Government for COVID-19 Oral Antiviral Treatment - 2021/11/24 - |
|
CDC Director Endorses Pfizer, Moderna Boosters for All US Adults - 2021/11/20 - |
|
Stroke: Large study shows which types of fat and dietary sources lower risk - 2021/11/10 - |
|
First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA - 2021/11/6 - |
|
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Children Ages 5 to 11 - 2021/10/31 - |
|
Using mRNA to Create the Elusive HIV Vaccine - 2021/10/26 - |
|
High bioactivity proteins for antibody drug conjugate (ADC) development - 2021/10/19 - |
|
FDA OKs New High-Dose Naloxone Product for Opioid Overdose - 2021/10/19 - |
|
In Atopic Dermatitis Trial, Abrocitinib Offers Faster Itch Relief Than Dupilumab - 2021/10/6 - |
|
First-in-Class TYK Inhibitor Shows Durable Effect for Psoriasis - 2021/10/2 - |
|
Top Questions Answered About COVID Boosters for Your Patients - 2021/09/26 - |
|
More older adults are taking drugs that can lead to falls - 2021/09/7 - |
|
mRNA vaccines reduce risk of infection by 91% for fully vaccinated - 2021/09/7 - |
|
Long COVID Symptoms Can Persist for More Than 1 Year, Study Shows - 2021/08/30 - |
|
No Sequelae From Lab Abnormalities in Pediatric Isotretinoin Study - 2021/07/12 - |
|
CDC and Pfizer at Odds Over Need for COVID-19 Booster Shots - 2021/07/12 - |
|
Antibiotic Linked to Rise in Early-Onset Colon Cancer? - 2021/07/7 - |
|
CDC recommends pregnant women get COVID-19 vaccine - 2021/06/30 - |
|
EAS Lipid Guidance: Start High-risk Patients on Combo Drug - 2021/06/30 - |
|
Cannabis could help manage symptoms of some neurological conditions - 2021/06/27 - |
|
Long COVID’ needs to be addressed by multiple specialties - 2021/06/27 - |
|
Researchers develop new therapeutic approach for treating acute myeloid leukemia - 2021/06/22 - |
|
Moderna Applies for Full Approval for Its Vaccine - 2021/06/2 - |
|
Novel Drug Approved by FDA for Some Bile Duct Cancers - 2021/06/2 - |
|
COVID-19: More evidence that monoclonal antibodies reduce risk of death - 2021/05/22 - |
|
Convalescent Plasma Flops for Hospitalized COVID Patients - 2021/05/19 - |
|
Obesity: New drug turns ‘energy-storing’ fat into ‘energy-burning’ fat - 2021/05/18 - |
|
COVID-19 Anticoagulation Trials 'Paused' for Futility, Safety - 2020/12/28 - |
|
Pfizer’s COVID-19 vaccine proves 90% effective in first results from Phase 3 clinical trial - 2020/11/14 - |
|
International Conference on Cell Science and Molecular Biology December 02-04, 2021 Rome, Italy - 2020/11/14 - |
|
Share your COVID experiences with 2 million+ researchers - 2020/09/30 - |
|
From Brain to Behavior: The Search for Biomarkers - 2020/09/26 - |
|
Happy Peer Review Week from ACS Publications - 2020/09/26 - |
|
Hologic Showcased Latest Advances at Virtual ECR Congress 2020 - 2020/08/22 - |
|
Korean Biopharmaceutical Firm Celltrion Launches Both Antigen and Antibody Testing Kits in the US - 2020/08/22 - |
|
Upcoming Events of the ACSE - 2020/08/18 - |
|
Introduction to testing for COVID-19 - 2020/08/9 - |
|
Prospective randomized trial of interventions for vincristine-related neuropathic pain - 2020/07/18 - |
|
COVID-19 resources: serological tests, face masks and benefits of physical activity - 2020/07/11 - |
|
FDA approves generic albuterol inhaler to mitigate shortages during pandemic - 2020/07/8 - |
|
What do we know for sure about hydroxychloroquine for COVID-19? Not much - 2020/07/8 - |
|
Webinars for the Week of July 6th - 2020/07/8 - |
|
COVID-19: Bacteriophage Could Decrease Mortality - 2020/06/29 - |
|
Animal Models of COVID-19 - 2020/06/28 - |
|
Social isolation can lead to depression in children long after current lockdown - 2020/06/28 - |
|
Is COVID-19 Risk Linked to Blood Type? - 2010/07/1 - |
